The chair has me firmly focused now on the drug courts envelope.
I had an opportunity with other Parliamentarians three or four years ago to get a look at the Toronto drug court up close and personal. It seemed like it was efficacious, but I was just curious about whether there has been any departmental study of the spending effectiveness for that. You have to invest in a new court, new procedures, but you get savings from diversion from other courts. You get improved outcomes, I understand, on the part of the persons attending regularly before the court. They're retained in the court system much longer, so there's a higher retention cost, but they're not incarcerated, so there are savings there.
Is there any document out there that attempts to reconcile the costs and benefits, even on an interim basis?